Document is current
Any future updates will be listed below
-
Authors
Riishede, Iben https://orcid.org/0000-0001-9353-8958
Rode, Line https://orcid.org/0000-0002-9080-3389
Lundegaard, Pia Rengtved https://orcid.org/0000-0002-8284-1844
Rand, Søren Albertsen
Dyrskjøt, Lars https://orcid.org/0000-0001-7061-9851
Larsen, Ole Halfdan
Ekelund, Charlotte Kvist
Pinborg, Anja https://orcid.org/0000-0002-8340-104X
Stender, Stefan https://orcid.org/0000-0003-0281-5900
Ghouse, Jonas https://orcid.org/0000-0002-9634-5964
- License Information
-
More Information
Article History
Received: 17 September 2025
Accepted: 6 March 2026
First Online: 13 April 2026
Competing interests
: J.G. has received lecture fees from Illumina and is a former employee of Novo Nordisk A/S. A.P. has received independent research grants and lecture fees from Abbott, IBSA, Gedeon Richter, Ferring and Merck A/S. A.P. is part of research advisory boards for Gedeon Richter and Ferring. All other authors declare no competing interests.
